These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34912345)

  • 21. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
    Chappell MC
    Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?
    Wiese OJ; Allwood BW; Zemlin AE
    Med Hypotheses; 2020 Nov; 144():110231. PubMed ID: 33254538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.
    Kinaneh S; Khamaysi I; Karram T; Hamoud S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular aspects of COVID-19.
    Kurz DJ; Eberli FR
    Swiss Med Wkly; 2020 Dec; 150():w20417. PubMed ID: 33382450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 and coagulation disorders in different organs.
    Vinayagam S; Sattu K
    Life Sci; 2020 Nov; 260():118431. PubMed ID: 32946915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
    Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
    Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
    Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: Risk Factors Associated with Infectivity and Severity.
    Fadl N; Ali E; Salem TZ
    Scand J Immunol; 2021 Jun; 93(6):e13039. PubMed ID: 33710663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
    Lou M; Yuan D; Liao S; Tong L; Li J
    J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.
    Mehrabadi ME; Hemmati R; Tashakor A; Homaei A; Yousefzadeh M; Hemati K; Hosseinkhani S
    Biomed Pharmacother; 2021 May; 137():111363. PubMed ID: 33582450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.
    Bank S; De SK; Bankura B; Maiti S; Das M; A Khan G
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33442728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection.
    Devaux CA; Camoin-Jau L
    Front Microbiol; 2022; 13():1042200. PubMed ID: 36519165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
    Del Turco S; Vianello A; Ragusa R; Caselli C; Basta G
    Thromb Res; 2020 Dec; 196():143-151. PubMed ID: 32871306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.
    Martins M; Fernandes MHV; Joshi LR; Diel DG
    J Virol; 2022 Feb; 96(3):e0145521. PubMed ID: 34817200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.